Find your path to Joseph
196 people in our graph share verified history with Joseph — schools, employers, funds. One of them is your warm intro.
David GreenwaldunlockedJoseph: together at Jaguar Gene Therapy (2020–2026)
Joseph: together at Takeda
×10Joseph: together at Tulane University
About
Joseph Nolan is President and Chief Executive Officer of Jaguar Gene Therapy, a company focused on developing gene therapies for severe genetic diseases. He has more than 30 years of experience in the pharmaceutical industry and previously served on the executive team at AveXis during the development and approval of ZOLGENSMA. Nolan has also held executive leadership roles at Lundbeck and Abbott Laboratories.
Executive at Jaguar Gene Therapy
Intro paths
→
In turn, Joseph can intro founders to Jaguar Gene Therapy's investors below.
Experience
- Jaguar Gene TherapyPresident and Chief Executive Officercurrent2020 — presentLake Forest, Illinois, United States
- AveXis, Inc.General Manager - US2018 — 2020Greater Chicago Area
- KJE Health Pharma Science, LLCPresident2017 — 2018Greater Chicago Area
- Dohmen Life Science ServicesPresident2016 — 2017Greater Chicago Area
- Marathon Pharmaceuticals, LLCChief Commercial Officer2014 — 2016Greater Chicago Area
- LundbeckChief Commercial Officer2006 — 2014Greater Chicago Area
- TakedaDirector of New Product Planning2005 — 2006Greater Chicago Area
- AbbottDirector of Marketing, Global Specialty Pharmaceuticals2001 — 2005Greater Chicago Area
Skills & more
Public SpeakingLeadership1Strategic Planning1Team Leadership1Sales1Business Development1Cross-functional Team Leadership4Partnership-buildingGlobal Experience1New Market Expansion1Marketing Strategy3Pharmaceutical Industry1
+12 more
Specialty PharmaGene TherapyProduct LaunchGlobal Product ManagementSpecialty PhValuationTraining DeliveryTraining & DevelopmentGlobal Cross-Functional Team LeadershipExecutive DevelopmentResearchTeam BuildingFrom Joseph's professional profile.
Frequently asked questions
- Who is Joseph Nolan?
- Joseph Nolan is President and Chief Executive Officer of Jaguar Gene Therapy, a company focused on developing gene therapies for severe genetic diseases. He has more than 30 years of experience in the pharmaceutical industry and previously served on the executive team at AveXis during the development and approval of ZOLGENSMA. Nolan has also held executive leadership roles at Lundbeck and Abbott Laboratories.
- Where did Joseph Nolan go to school?
- Joseph Nolan studied at University of Notre Dame (Master of Business Administration - MBA, Marketing); Tulane University (Bachelor of Science - BS, Finance, General).
Same school
Also attended University of Notre Dame438
Doug GrohAdvisor at CincyTechMimi DunnSenior Investment Analyst at Catalyst Health VenturesJim HuntGeneral Partner at Lavrock VenturesTristan HuntPartner at Averin CapitalJoanne IshamSenior Advisory Board at IronGate Capital AdvisorsAlex FlorAssociate at TCV
+ 432 more
Also attended Tulane University185
Chris BrittCo-founder & CEO of ChimeSam KingAssociate General Counsel at Sapphire VenturesSteve PaulVenture Partner at Third Rock Ventures; physician-scientist in neuroscience and CNS drug discoveryAnna Shults HeldEditorial Director at Scale Venture PartnersAddie RaschePrincipal at Silverton PartnersZane SalamehAnalyst at Volition Capital
+ 179 more
Shared employers
Also worked at Jaguar Gene Therapy2
Also worked at AveXis, Inc.3
Also worked at Dohmen Life Science Services3
Also worked at Lundbeck22
Christian Krog-JensenInvestor at Almi InvestJørgen Søberg PetersenSenior Partner at Novo HoldingsCamilla Petrycer HansenPartner at Novo HoldingsEric FloydRegulatory Advisor at 2Flo VenturesErik SteffensenExpert advisor at VÅR VenturesNicolas FavreChief Business Officer, Business Development & Commercial at Debiopharm Innovation Fund
+ 16 more